Video
Author(s):
Dr Susan Catalano of Cognition Therapeutics talks the science behind the Icelandic Mutation and their potential upcoming drug for the treatment of Alzheimer disease.
Dr Catalano is the co-founder and chief science officer at Cognition Therapeutics.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.